Stockholders’ Equity and Convertible Preferred Stock - Schedule of Warrant Activity (Details) - Warrant [Member] |
6 Months Ended | |
|---|---|---|
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
|
| Schedule of Warrant Activity [Line Items] | ||
| Granted, Warrants | shares | 7,752,108 | |
| Granted, Weighted Average Exercise Price | $ / shares | $ 3.97 | |
| Granted, Total Intrinsic Value | $ | ||
| Expired, Warrants | shares | (87,598) | |
| Expired, Weighted Average Exercise Price | $ / shares | $ 28.74 | |
| Expired, Total Intrinsic Value | $ | ||
| Exercised, Warrants | shares | (591,885) | |
| Exercised, Weighted Average Exercise Price | $ / shares | $ 3.94 | |
| Exercised, Total Intrinsic Value | $ | ||
| Number of shares, ending balance | shares | 444,796 | 7,517,421 |
| Weighted Average per share, ending balance | $ / shares | $ 29.25 | $ 5.22 |
| Outstanding ending balance, Total Intrinsic Value | $ | ||
| Outstanding ending balance, Weighted Average Remaining Contractual Life | 1 year 2 months 12 days | 4 years 5 months 8 days |
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards expired during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
- Definition Exercised, total intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of expired award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Amount of aggregate intrinsic value grants under other than options. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|